1Consensus development conference on antipsychotic drugs and obesity and diabetes (2004) Diabetes Care. 27:596-601.
2Rettenbacher MA, Hofer A, Kemmler G and Fleischhacker WW (2010) Neutropenia induced by second generation antipsychotics: a prospective investigation. Pharmacopsychiatry 43:41-4.
3Duggal HS, Gates C and Pathak PC. (2004) Olanzapine-induced neutropenia: mechanism and treatment. J Clin Psychopharmacol. 24:234-235.
4Stergiou V, Bozikas VP, Garyfallos G, Nikolaidis N, Lavrentiadis G et.al (2005) Olanzapine-induced leucopenia and neutropenia. Prog Neuropsychopharmacol Biol Psychiatry. 29:992-994.
5Cowan C and Oakley C. (2007) Leukopenia and neutropenia induced by quetiapine. Prog Neuropsychopharmacol Biol Psychiatry. 31:292-294.
6Li X and Cameron MD. (2012) Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis. Chem Res Toxicol. 25:1004-1011.
7Tseng CC. (2011) Neutropenia during risperidone treatment. The Journal of neuropsychiatry and clinical neurosciences 23: E19.
8Manfredi G, Solfanelli A, Dimitri G, Cuomo I, Sani G, et.al (2013) Risperidone-induced leukopenia: a case report and brief review of literature. Gen Hosp Psychiatry. 35: 102.e3-6.
9Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et.al (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the rheumatic diseases 61:554-558.
10Aoki A, Ohno S, Ueda A, Ideguchi H, Ohkubo T, et.al (2000) [Hematological abnormalities of primary Sjogren's syndrome]. Nihon Rinsho Men'eki Gakkai kaishi 23:124-128.
11Qiao L, Chen J, Leng XM, Zhang W, Han B, et.al (2016) Agranulocytosis and mixed-type autoimmune hemolytic anemia in primary sjogren's syndrome: a case report and review of the literature. Int J Rheum Dis. 19: 1351-1353.
12Koh JH, Lee J, Chung SH, Kwok SK and Park SH. (2015) Relation of Autoimmune Cytopenia to Glandular and Systemic Manifestations in Primary Sjogren Syndrome: Analysis of 113 Korean Patients. The Journal of rheumatology 42:1817-24.
13Biswas A, Mittal P, Chaturvedi S and Prasad A. (2000) Risperidone induced cytopenias. The Journal of the Association of Physicians of India 48:1122-1123.
14Dernovsek Z and Tavcar R. (1997) Risperidone-induced leucopenia and neutropenia. The British journal of psychiatry: the journal of mental science 171:393-394.
15Sluys M, Guzelcan Y, Casteelen G and de Haan L. (2004) Risperidone-induced leucopenia and neutropenia: a case report. European psychiatry: the journal of the Association of European Psychiatrists 19:117.
16Uzun S, Kozumplik O, Jakovljevic M and Folnegovic-Smalc V. (2008) Leukopenia during therapy with risperidone long-acting injectable: two case reports. Journal of clinical psychopharmacology 28:713-714.
17Kim JN, Lee BC, Choi IG, Jon DI and Jung MH. (2011) Paliperidone-induced leukopenia and neutropenia: a case report. Progress in neuro-psychopharmacology & biological psychiatry 35:284-285.
18Mishra AC and Mohanty B. (2010) Effects of lactational exposure of olanzapine and risperidone on hematology and lymphoid organs histopathology: a comparative study in mice neonates. European journal of pharmacology 634:170-177.